Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Bioresorbable polymer unveiled at Houston conference

Secant Medical : 04 October, 2013  (New Product)
Within the medical device industry there is a need for new biomaterials that address the scientific and technical requirements of regenerative medicine applications. Peter D Gabriele, Vice President of Emerging Technology at Secant Medical, will discuss at the MedTech Polymers Conference in Houston, the development and prospective uses of a novel bioelastomer. Gabriele’s presentation, "A Novel Bioresorbable Polymer Option for Regenerative Medicine", is to take place on Monday, 14 October at 12:05pm at the Reliant Center.
When it comes to the medical applications of synthetic materials like plastics, we may have just scratched the surface in terms of what is possible, Gabriele believes. "Future biomaterials have the potential of not only being tolerated by the body but closely integrating with it. The more we know about the mechanism of healing, the better we can get at designing polymers that can accommodate the wound healing process.”
 
The Holy Grail for treating cardiovascular disease, according to Gabriele, would be to reconstruct a synthetic bioresorbable small-bore vessel less than 6mm in diameter. “The challenge is to provide performance in a mechanically dynamic environment while simultaneously regenerating vascular tissue within a degradable scaffold,” he adds.
 
The engineering of bioresorbable implant devices is still a young field. “We’re still learning a lot about tissue engineering, tissue regeneration, materials science, and materials interaction with the body,” Gabriele notes. “With progress that’s been made, we’ll be able to start designing materials for the future. Key to this is the idea of metabolic breakdown products: creating bioresorbable materials where the body can handle the breakdown products safely as opposed to their being contaminants.”
 
“Within the medical device industry there is a hesitance to adopt novel technologies due to regulations,” said Gabriele. “However, while being mindful of regulatory compliance, one must also have the courage to take risks. I look forward to sharing the work we are doing for the research and commercial development of bioelastomers.”
 
  • The MedTech Polymers Conference is designed to tackle the industry’s most critical concerns over the use of the polymers in medical devices and discover new areas for investment and opportunity. The conference takes place during the Plastec Texas tradeshow event, from 14 to 16 October.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   ¬© 2012 NewMaterials.com
Netgains Logo